Inflammatory breast cancer with excellent response to pembrolizumab-chemotherapy combination: A case report. - Kharel Z; Nemer OP; Xi W; Upadhayaya B; Falkson CI; O'Regan RM; Dhakal A (Breast disease, 2022)